POTASSIUM PHOSPHATES (POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM ) — FDA Approval ANDA217726 (SOMERSET THERAPS LLC)
POTASSIUM PHOSPHATES (POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM ) — FDA Approval ANDA217726 (SOMERSET THERAPS LLC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: POTASSIUM PHOSPHATES; Active ingredients: POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC; Application numb
| Brand name | POTASSIUM PHOSPHATES |
|---|---|
| Active ingredients | POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC |
| Application number | ANDA217726 |
| Sponsor | SOMERSET THERAPS LLC |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20240711 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →